Clear Scientific News

Clear Scientific's Executive Vice President presents at the 18th Annual Conference in Behavior, Biology, and Chemistry Translational Research in Substance Use Disorders

San Antonio, TX | March 2025 On March 23, 2025, Dr. Xinhua Li, Executive Vice President of Clear Scientific Inc., a clinical-stage...

Apr 8

National Institute on Drug Abuse Highlights need for sequestrants like Clear Scientific’s First-in-Class Methamphetamine Antidote CS-1103 in 2025 Outlook

Cambridge MA | Feb 2025 In their blog entry Reflecting on NIDA’s 50th year and looking to 2025 , published January 8, 2025, the National...

Mar 11

Clear Scientific Presents at the Advances in Developing Medical Countermeasures Against Opioids and Drug-Induced Respiratory Depression Conference

Rockville MD | Dec 2024 On December 17-18, 2024, Dr. Xinhua Li and Dr. Mitch Zakin of Clear Scientific Inc., a clinical-stage...

Dec 30, 2024

Clear Scientific Attends Community Cares Clinic Open House

Roxbury MA | Dec 2024 On December 12th, 2024, Peter Howe, CFO and Winston Henderson, VP General Counsel, attended the Open House hosted...

Dec 16, 2024

Clear Scientific team participates in Shatterproof Walk to End Addiction Stigma

Boston MA | Oct 2024 Last Saturday, the Clear Scientific team joined the Shatterproof Walk to End Addiction Stigma at Carson Beach in...

Oct 10, 2024

Clear Scientific Attends 2024 American College of Emergency Physicians (ACEP) Scientific Assembly

Las Vegas, NV | Oct 2024 Peter Howe and Charlotte Leggett from Clear Scientific attended the 2024 American College of Emergency...

Oct 4, 2024

Clear Scientific Awarded $3M NIDA Grant to Support Development of Antidote for Combinations of Fentanyl and Xylazine

Cambridge MA | Sept 2024 Clear Scientific, a clinical-stage biopharmaceutical company, today announced a $3M award from the National...

Sep 30, 2024

Clear Scientific Attends Annual Meeting of the West Virginia Chapter of the American College of Emergency Physicians

Roanoke, WV | Sept 2024 On September 19th, Winston Henderson, VP, General Counsel, Peter Howe, CFO, and Charlotte Leggett, Scientific...

Sep 23, 2024

Clear Scientific Reports Positive Topline Phase 1 Clinical Trial Data for CS-1103

Cambridge MA | Sept 2024 CAMBRIDGE, Mass., Sept. 10, 2024 /PRNewswire/ -- Clear Scientific, Inc., a clinical-stage biopharmaceutical...

Sep 10, 2024

Clear Scientific featured in latest issue of Eureka: A Dose of Science sponsored by Charles River Laboratories.

Cambridge MA | June 2024 Clear Scientific is featured in the June 24, 2024 issue of Eureka: A Dose of Science, a multimedia platform...

Jun 28, 2024

Clear Scientific presents at 86th Annual Scientific Meeting of the College on Problems of Drug Dependence.

Montreal, Canada | June, 2024 Dr. Xinhua Li, Executive Vice President of Drug Development at Clear Scientific Inc, a Cambridge, MA...

Jun 24, 2024

Clear Scientific is featured in the latest podcast episode of Vital Science sponsored by Charles River Laboratories

Cambridge, MA | May 22, 2024 Clear Scientific is featured in the latest episode of Vital Science, a podcast unveiling the compelling...

May 22, 2024

CS Inc. presents at 2024 Rx and Illicit Drug Summit.

Atlanta, GA | April 1, 2024 Clear Scientific presented a poster titled: Hope in Methamphetamine Addiction and Overdose, Authors: P....

Apr 10, 2024

Clear Scientific Awarded up to $15M from NIDA for Continued Development of Fentanyl Antidote.

Cambridge, MA | Nov 2023 Clear Scientific, a clinical-stage biopharmaceutical company, today announced an award from the National...

Nov 2, 2023

Clear Scientific Awarded $12M NIDA Grant for Continued Development of Meth Antidote.

Cambridge, MA | Nov 2023 Clear Scientific, a clinical-stage biopharmaceutical company, today announced a $12M award from the National...

Nov 2, 2023

Clear Scientific to Start Phase 1 Trial for Stimulant Antidote.

Cambridge, MA | Oct 2023 Clear Scientific Inc., a Cambridge MA based biopharmaceutical company, announced that the FDA has approved its...

Oct 30, 2023

Spotlight on Clear Scientific’s antidote for xylazine-laced fentanyl overdose by NIH/NIDA

Cambridge, MA | Oct 2023 https://www.medpagetoday.com/psychiatry/addictions/106682 Clear Scientific's antidote CS-1103 was featured in...

Oct 13, 2023

Fentanyl mixed with cocaine or meth is driving the 4th wave of the overdose crisis reported by NPR.

Cambridge, MA | Sept 2023 https://www.npr.org/sections/health-shots/2023/09/14/1199396794/fentanyl-mixed-with-cocaine-or-meth-is-driving...

Sep 15, 2023

Clear Scientific Recognizes International Overdose Awareness Day

Cambridge, MA | August 2023 Clear Scientific joins those around the world who recognize the need to bring awareness to the international...

Aug 31, 2023

Clear Scientific participates in NIDA/Babson College L-SPRINT program on Substance Use Disorder

Boston, MA | August 2023 On August 17th 2023 Winston Henderson, General Counsel of Clear Scientific Inc., participated as a panelist in...

Aug 28, 2023

CS Inc. presents at 85th Annual Scientific Meeting of the College on Problems of Drug Dependence.

Denver, CO | June 2023 Clear Scientific presented a poster titled: A Novel Approach to Treat Fentanyl Intoxication, Authors: X. Li, P....

Jun 30, 2023

CS Inc. antidote featured in Charles River Lab's Eureka Blog: Drug Modality Game Changers.

Cambridge, MA | May 2023 Clear Scientific's CS 1103 antidote was featured in Charles River Laboratories Eureka Blog : Drug Modality...

May 31, 2023

CEO and VP of R&D present at the Charles River Sixth Annual World Congress.

Cambridge, MA | May 2023 Shekar Shetty, CEO and Dr. Piercen Oliver, VP R&D of Clear Scientific presented at the Charles River Sixth...

May 12, 2023

Clear Scientific announces the addition of Dr. Roneet Lev and Dr. Marc Rubin to its Advisory Board

Cambridge, MA | March 2023 Clear Scientific, Inc., a leading biopharmaceutical company developing novel therapies for treating...

Apr 12, 2023